促性腺激素释放激素拮抗剂对盆腔放疗所致卵巢功能损伤的防护作用

谭燕; 孙春堂; 颜高姝; 范子煊; 刁鹏; 彭倩; 罗兴波; 王卫东; 谭燕; 孙春堂; 颜高姝; 范子煊; 刁鹏; 彭倩; 罗兴波; 王卫东

doi:10.3760/cma.j.issn.1673-4114.2018.05.006

[1]

Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages[J]. Hum Reprod Update, 2009, 15 (3):359-377. DOI:10.1093/humupd/dmn063.

[2]

Said RS, El-Demerdash E, Nada AS, et al. Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly (ADP-ribose) polymerase 1 (PARP-1)[J]. Biochem Pharmacol, 2016, 103:140-150. DOI:10.1016/j.bcp.2016.01.019.

[3]

谭燕, 颜高姝, 刁鹏, 等.促性腺激素释放激素激动剂对辐射所致大鼠卵巢功能损伤的防护作用研究[J].国际放射医学核医学杂志, 2017, 41 (5):314-320. DOI:10.3760/cma.j.issn.1673-4114. 2017.05.002.
Tan Y, Yan GS, Diao P, et al. Protective effect of gonadotropin-releasing hormone agonist on ovarian functional impairment caused by radiation in rats[J]. Int J Radiat Med Nucl Med, 2017, 41 (5):314-320. doi: 10.3760/cma.j.issn.1673-4114.2017.05.002

[4]

Del MastroL. Temporary ovarian suppression with goserelin and ovarian function protection in patients with breast cancer undergoing chemotherapy[J]. J Clin Oncol, 2011, 29 (24):3339-3340. DOI:10.1200/JCO.2011.36.9942.

[5]

Guenther V, Alkatout I, Junkers W, et al. Fertility Preservation in Female Patients with Breast Cancer-a Current Dverview[J]. Geburtshife FrauenheilkD, 2017, 77 (10):1088-1094. DOI:10.1055/s-0043-119543.

[6]

Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy[J]. N Engl J Med, 2015, 372 (10):923-932. DOI:10.1056/NEJMoa1413204.

[7]

Baines E. GnRH antagonist protects ovarian function[J]. Lancet Oncol, 2007, 8 (8):675.

[8]

Lobo RA. Potential options for preservation of fertility in women[J]. N Engl J Med, 2005, 353 (1):64-73. DOI:10.1056/NEJMra043475.

[9]

Rodriguez-Wallberg K, Turan V, Munster P, et al. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?[J]. Ann Oncol, 2016, 27 (2):357. DOI:10.1093/annonc/mdv554.

[10]

Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF:a systematic review and meta-analysis accounting for patient type[J]. Hum Reprod Update, 2017, 23 (5):560-579. DOI:10.1093/humupd/dmx017.

[11]

Demeestere I, Brice P, Peccatori FA, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma:1-year follow-up of a prospective randomized trial[J]. J ClinOncol, 2013, 31 (7):903-909. DOI:10.1200/JCO.2012.42.8185.

[12]

Song G, Chen Y, Liang C, et al. Catalase-Loaded TaOxNanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy[J]. Adv Mater, 2016, 28 (33):7143-7148. DOI:10.1002/adma.201602111.